Activation of the mechanistic target of rapamycin (mTOR) pathway contributes to the hyperproliferative phenotype of ALL, and recent genome-wide knockout screens have confirmed mTOR complex 1 (mTORC1) as a crucial mediator of glucocorticoid sensitivity in B-ALL [172]. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.